Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FT061452
- Development stage
- Unknown
- Lead developer
- ProImmune
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
FT061452 is a proprietary dietary supplement, also known as ProImmune or Immune Formulation 200 (IF200), designed to serve as a precursor for the endogenous synthesis of glutathione (GSH). It was evaluated in clinical trials led by the Charles R. Drew University of Medicine and Science to determine its ability to increase serum and intracellular glutathione levels and improve vascular function in healthy adults. The formulation aims to address oxidative stress, which is implicated in aging and various chronic conditions such as cardiovascular disease and diabetes. By providing the necessary amino acid building blocks—specifically cysteine, glycine, and glutamic acid—FT061452 supports the body's natural production of glutathione, a potent intracellular antioxidant.
- Brand names
- ProImmuneImmune Formulation 200
- Other names
- glutathione precursor
02
Targets
GSH (Glutathione synthesis / redox)
Beyond the preview
Go deeper on FT061452.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FT061452.